Virtu Financial LLC raised its stake in McKesson Co. (NYSE:MCK) by 47.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,114 shares of the company’s stock after buying an additional 3,590 shares during the period. Virtu Financial LLC’s holdings in McKesson were worth $1,301,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the business. Proficio Capital Partners LLC grew its position in shares of McKesson by 161.2% in the fourth quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock valued at $25,000 after purchasing an additional 137 shares during the last quarter. Bedel Financial Consulting Inc. grew its position in shares of McKesson by 165.2% in the fourth quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock valued at $26,000 after purchasing an additional 147 shares during the last quarter. Dubuque Bank & Trust Co. grew its position in shares of McKesson by 106.7% in the first quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock valued at $40,000 after purchasing an additional 176 shares during the last quarter. Old North State Trust LLC grew its position in shares of McKesson by 53.3% in the fourth quarter. Old North State Trust LLC now owns 391 shares of the company’s stock valued at $43,000 after purchasing an additional 136 shares during the last quarter. Finally, IMS Capital Management acquired a new stake in shares of McKesson in the third quarter valued at approximately $57,000. 86.60% of the stock is owned by institutional investors.
Several research firms have recently commented on MCK. Zacks Investment Research upgraded shares of McKesson from a “sell” rating to a “hold” rating in a research report on Wednesday, April 10th. Wolfe Research initiated coverage on shares of McKesson in a research report on Tuesday, April 2nd. They set an “outperform” rating on the stock. UBS Group initiated coverage on shares of McKesson in a research report on Thursday, January 17th. They set a “neutral” rating and a $134.00 target price on the stock. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Barclays restated a “hold” rating and set a $130.00 target price on shares of McKesson in a research report on Friday, February 1st. One analyst has rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $134.90.
In other McKesson news, EVP Lori A. Schechter sold 7,700 shares of McKesson stock in a transaction on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total value of $946,792.00. Following the transaction, the executive vice president now owns 10,000 shares in the company, valued at approximately $1,229,600. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.87% of the stock is owned by company insiders.
Shares of NYSE MCK opened at $116.05 on Monday. McKesson Co. has a 1 year low of $106.11 and a 1 year high of $160.84. The company has a market cap of $21.90 billion, a P/E ratio of 9.20, a PEG ratio of 1.16 and a beta of 1.24. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.81.
McKesson (NYSE:MCK) last announced its earnings results on Thursday, January 31st. The company reported $3.40 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The firm had revenue of $56.21 billion for the quarter, compared to analyst estimates of $55.27 billion. During the same quarter last year, the business earned $3.41 earnings per share. Sell-side analysts anticipate that McKesson Co. will post 13.55 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 1st were issued a $0.39 dividend. The ex-dividend date was Thursday, February 28th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.34%. McKesson’s dividend payout ratio (DPR) is presently 12.36%.
COPYRIGHT VIOLATION WARNING: This piece was published by Macon Daily and is the sole property of of Macon Daily. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://macondaily.com/2019/04/15/mckesson-co-mck-shares-bought-by-virtu-financial-llc.html.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Story: Are 12b-1 Fees Affecting Your Mutual Fund Performance?
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.